Novel NeuroAIDS Therapies: Integrated Preclinical/Clinical Program (IPCP) (U19)

The summary for the Novel NeuroAIDS Therapies: Integrated Preclinical/Clinical Program (IPCP) (U19) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Novel NeuroAIDS Therapies: Integrated Preclinical/Clinical Program (IPCP) (U19): -Purpose. The National Institute of Mental Health (NIMH) requests applications for research on the development of novel neuroAIDS therapeutics. This funding opportunity announcement (FOA) fosters bench to bedside research comprised of preclinical research, studies on translational animal models, and pilot clinical projects. In the past, HIV-related drug development efforts have focused primarily on viral targets and a small number of host targets. The Integrated Preclinical/Clinical Program (IPCP) supports drug development efforts focused on new targets, particularly those targets that may have immunomodulatory, neurobehavioral and/or neuroprotective actions in the context of HIV infection. A minimum of three interrelated research projects and an Administrative Core must be proposed. At least one component (research project) must be derived from industry (i.e., pharmaceutical, chemical, bioengineering or biotechnological companies). A Scientific Advisory Panel (SAP) for each award under this FOA will be constituted within 6 months of the award. This funding opportunity AI-06-009, was originally issued jointly with NIAID and NIMH. -Mechanism of Support. This FOA will utilize the multi-project Cooperative Agreement (U19) award mechanism -Funds Available and Anticipated Number of Awards. NIMH anticipates awarding approximately $2-3 million dollars to fund 1-2 new and/or competing continuation grants. -Budget and Project Period. Budget limitations for individual applications are specified in Section II.2. The total project period for an application submitted in response to this funding opportunity may not exceed five years.

Federal Grant Title:	Novel NeuroAIDS Therapies: Integrated Preclinical/Clinical Program (IPCP) (U19)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-MH-09-040
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.242
CFDA Descriptions:	Mental Health Research Grants
Current Application Deadline:	No deadline provided
Original Application Deadline:	Sep 12, 2008
Posted Date:	Jul 15, 2008
Creation Date:	Jul 15, 2008
Archive Date:	Oct 13, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments Private institutions of higher education State governments Public and State controlled institutions of higher education Special district governments Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH...; • Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional...; • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...; • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...; • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...; • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...; • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...